Irressat en es it fr

Irressat Brand names, Irressat Analogs

Irressat Brand Names Mixture

  • No information avaliable

Irressat Chemical_Formula


Irressat RX_link

Irressat fda sheet

Irressat FDA

Irressat msds (material safety sheet)

Irressat MSDS

Irressat Synthesis Reference

No information avaliable

Irressat Molecular Weight

446.902 g/mol

Irressat Melting Point

No information avaliable

Irressat H2O Solubility

Sparingly soluble (<pH4)

Irressat State


Irressat LogP


Irressat Dosage Forms


Irressat Indication

For the continued treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of either platinum-based or docetaxel chemotherapies.

Irressat Pharmacology

Gefitinib inhibits the intracellular phosphorylation of numerous tyrosine kinases associated with transmembrane cell surface receptors, including the tyrosine kinases associated with the epidermal growth factor receptor (EGFR-TK). EGFR is expressed on the cell surface of many normal cells and cancer cells.

Irressat Absorption

Absorbed slowly after oral administration with mean bioavailability of 60%.

Irressat side effects and Toxicity

No information avaliable

Irressat Patient Information

Irressat Organisms Affected

Humans and other mammals